Impactiviti Daily 093009

TODAY’S NEWS Novartis’ new MS drug (FTY 720) looking good in Phase III trials. New results just released. Vertex – takeover target? For a company looking to expand into Hepatitis C, Vertex is a prime candidate. Boston Scientific and J&J making peace with the lawyer-enriching stent suits. RECOMMENDED Call center/phone rep training. The Impactiviti Partner [...]

Read Full Post »

Pharma Social Media Roundup – End of September 09

There’s a huge amount of stuff going on in pharma social media this month. Here’s a distillation of news and resources for your perusal: > Google’s Sidewiki – now users can leave comments on any site (including yours). Game-changer? Annoyance? What do you think? > Slideshow – Pharma’s Top 10 Efforts in Social Media > [...]

Read Full Post »

Impactiviti Daily 092909

Where to get your overview of Social Media in Pharma? Right here: http://bit.ly/socialrx TODAY’S NEWS Pharma’s new hot properties – vaccines. Boehringer Ingelheim pressing forward with its experimental DPP-4 inhibitor for diabetes – Boehringer Ingelheim Pharmaceuticals, Inc. today announced the conclusion of the linagliptin pivotal Phase III clinical trials, including more than 4,000 patients in [...]

Read Full Post »

Google’s Sidewiki – Game-changer for Pharma Social Media?

Take a look at the screen shot below, from Pfizer’s homepage. Believe it or not, I, or anyone else, can now leave comments “on” any website (such as Pfizer.com) using a new tool (currently in beta) from Google, called Sidewiki. Game-changer? You bet. While the use of Google’s Sidewiki has ramifications across the entire web, [...]

Read Full Post »

Impactiviti Daily 092809

Now Available – Archived interview on Social Media in Pharma last Friday with Paul Chaney – feel free to forward the link (http://bit.ly/29kAoN) to your colleagues. TODAY’S NEWS Abbott wins the bidding for Solvay’s drug unit – Abbott Laboratories will announce today the €5bn ($7.3bn) acquisition of Solvay’s pharmaceutical company, bringing a five-month takeover battle [...]

Read Full Post »

Impactiviti Daily 092509

Tune in TODAY – I’ll be doing a live on-line interview on Social Media in Pharma with Paul Chaney – starts at 1 pm EST (just use the call-in number – see the link). Also, here’s a page on my site with all sorts of social media resources for pharma professionals: http://bit.ly/socialrx TODAY’S NEWS AstraZeneca’s [...]

Read Full Post »

PharmaMed Conference – Live!

We’ll be giving live updates of the PharmaMed conference from Princeton on Sept. 23 and 24th – but also, you can get a live stream (using CoverItLive) of all the tweets coming from various social media users at the conference (and interacting from outside the conference using the #PharmaMed hashtag) on Twitter. Launch the CoverItLive [...]

Read Full Post »

Impactiviti Daily 092209

See the newly-re-launched Impactiviti Collection e-newsletter! Here’s a link to the on-line sample; you can sign up to receive the Connection (~every two weeks) right here. TODAY’S NEWS Pfizer and Wyeth to sell off some Animal Health assets to Boehringer-Ingelheim. Speaking of B-I, here’s a presentation from them on how they successfully use Twitter. Boehringer [...]

Read Full Post »

Impactiviti Daily 092109

See the newly-re-launched Impactiviti Collection e-newsletter! Here’s a link to the on-line sample; you can sign up to receive the Connection (~every two weeks) right here. TODAY’S NEWS It’s going to be a big week for Social Media in Pharma. Here’s the scoop. Cancer drug Nexavar shows efficacy in breast cancer – Bayer and Onyx [...]

Read Full Post »

Coming Up: A Big Week in Pharma Social Media

It’s only Monday morning and already the news hopper here at Impactiviti is brim-full with pharma social media stuff. That’s a good thing! The Biggest Deal – Finally, after months of cajoling from all quarters (and John Mack gets a big handclap for his relentless calls to make this happen), the FDA has decided to [...]

Read Full Post »